Raphas Co., Ltd. Logo

Raphas Co., Ltd.

Develops and manufactures dissolving microneedle patches for drug delivery.

214260 | KO

Overview

Corporate Details

ISIN(s):
KR7214260002
LEI:
Country:
South Korea
Address:
서울특별시 강서구 마곡중앙8로1길 62 라파스, 강서구

Description

Raphas Co., Ltd. is a biotechnology company specializing in advanced drug delivery systems. The company develops and manufactures biodegradable, dissolving microneedles using its proprietary DEN technology, a transdermal delivery platform. This technology is applied to create patches for a range of cosmetic and therapeutic needs, including anti-aging, wrinkle reduction, whitening, and acne treatment. Raphas commercializes its products through its own cosmetics brand, Acropass, and also offers manufacturing services for custom patch development.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-03-05 00:00
주식매수선택권부여에관한신고
Korean 15.6 KB
2025-03-05 00:00
주주총회소집공고
Korean 189.7 KB
2025-03-05 00:00
의결권대리행사권유참고서류
Korean 179.9 KB
2025-02-28 00:00
교환사채(해외교환사채포함)발행후만기전사채취득
Korean 8.7 KB
2025-02-24 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.8 KB
2025-02-24 00:00
주주총회소집결의
Korean 6.6 KB
2025-02-07 00:00
증권발행결과(자율공시)
Korean 5.6 KB
2025-02-05 00:00
주요사항보고서(전환사채권발행결정)
Korean 69.0 KB
2025-01-24 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2025-01-24 00:00
주식등의대량보유상황보고서(일반)
Korean 117.1 KB
2025-01-24 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.0 KB
2024-12-20 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.6 KB
2024-12-20 00:00
주식등의대량보유상황보고서(일반)
Korean 121.7 KB
2024-12-20 00:00
임원ㆍ주요주주특정증권등거래계획보고서
Korean 39.5 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB

Automate Your Workflow. Get a real-time feed of all Raphas Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Raphas Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Raphas Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.